3-1-1H--4--2- PHARMACEUTICAL COMPOSITIONS COMPRISING 3-1-1H-IMIDAZOL-4-YLETHYL-2-METHYLPHENYLMETHANOL
본 발명은 [3-(1-(1H-이미다졸-4-일)에틸)-2-메틸페닐] 메탄올 또는 이것의 거울상체, 이것의 호변체, 이들을 함유하는 약제학적 조성물의 치료적 유효량을 투여하는 단계를 포함하는 이러한 치료가 필요한 대상체에서 안압을 강하시키는 방법 및 및 약제로서 이들의 용도에 관한 것이다. The present invention provides a pharmaceutical composition comprising (S)-(3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl)methanol or a salt...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng ; kor |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | DONELLO JOHN E GIL DANIEL W DIBAS MOHAMMED I |
description | 본 발명은 [3-(1-(1H-이미다졸-4-일)에틸)-2-메틸페닐] 메탄올 또는 이것의 거울상체, 이것의 호변체, 이들을 함유하는 약제학적 조성물의 치료적 유효량을 투여하는 단계를 포함하는 이러한 치료가 필요한 대상체에서 안압을 강하시키는 방법 및 및 약제로서 이들의 용도에 관한 것이다.
The present invention provides a pharmaceutical composition comprising (S)-(3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl)methanol or a salt thereof for use in a method of treating a condition in a mammal selected from ischemic neuropathy, optic neuropathy, corneal pain, a retinal degenerative condition, skin erythema (redness) and inflammation, rosacea and acne. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR20190133071A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR20190133071A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR20190133071A3</originalsourceid><addsrcrecordid>eNrjZEg11jXUNfTQ1TXR1TXSVQjwcAzydXR2DQ3xdHb0UXD29w3wD_YM8fT3CwZzgjyDPf3cFaCaPH09XRyj_H2AmiN9XEM8In2AZviCGQEern6RPiC2o5-_Dw8Da1piTnEqL5TmZlB2cw1x9tBNLciPTy0uSExOzUstifcOMjIwtDQwNDY2MDd0NCZOFQCe2zS-</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>3-1-1H--4--2- PHARMACEUTICAL COMPOSITIONS COMPRISING 3-1-1H-IMIDAZOL-4-YLETHYL-2-METHYLPHENYLMETHANOL</title><source>esp@cenet</source><creator>DONELLO JOHN E ; GIL DANIEL W ; DIBAS MOHAMMED I</creator><creatorcontrib>DONELLO JOHN E ; GIL DANIEL W ; DIBAS MOHAMMED I</creatorcontrib><description>본 발명은 [3-(1-(1H-이미다졸-4-일)에틸)-2-메틸페닐] 메탄올 또는 이것의 거울상체, 이것의 호변체, 이들을 함유하는 약제학적 조성물의 치료적 유효량을 투여하는 단계를 포함하는 이러한 치료가 필요한 대상체에서 안압을 강하시키는 방법 및 및 약제로서 이들의 용도에 관한 것이다.
The present invention provides a pharmaceutical composition comprising (S)-(3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl)methanol or a salt thereof for use in a method of treating a condition in a mammal selected from ischemic neuropathy, optic neuropathy, corneal pain, a retinal degenerative condition, skin erythema (redness) and inflammation, rosacea and acne.</description><language>eng ; kor</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20191129&DB=EPODOC&CC=KR&NR=20190133071A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20191129&DB=EPODOC&CC=KR&NR=20190133071A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DONELLO JOHN E</creatorcontrib><creatorcontrib>GIL DANIEL W</creatorcontrib><creatorcontrib>DIBAS MOHAMMED I</creatorcontrib><title>3-1-1H--4--2- PHARMACEUTICAL COMPOSITIONS COMPRISING 3-1-1H-IMIDAZOL-4-YLETHYL-2-METHYLPHENYLMETHANOL</title><description>본 발명은 [3-(1-(1H-이미다졸-4-일)에틸)-2-메틸페닐] 메탄올 또는 이것의 거울상체, 이것의 호변체, 이들을 함유하는 약제학적 조성물의 치료적 유효량을 투여하는 단계를 포함하는 이러한 치료가 필요한 대상체에서 안압을 강하시키는 방법 및 및 약제로서 이들의 용도에 관한 것이다.
The present invention provides a pharmaceutical composition comprising (S)-(3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl)methanol or a salt thereof for use in a method of treating a condition in a mammal selected from ischemic neuropathy, optic neuropathy, corneal pain, a retinal degenerative condition, skin erythema (redness) and inflammation, rosacea and acne.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZEg11jXUNfTQ1TXR1TXSVQjwcAzydXR2DQ3xdHb0UXD29w3wD_YM8fT3CwZzgjyDPf3cFaCaPH09XRyj_H2AmiN9XEM8In2AZviCGQEern6RPiC2o5-_Dw8Da1piTnEqL5TmZlB2cw1x9tBNLciPTy0uSExOzUstifcOMjIwtDQwNDY2MDd0NCZOFQCe2zS-</recordid><startdate>20191129</startdate><enddate>20191129</enddate><creator>DONELLO JOHN E</creator><creator>GIL DANIEL W</creator><creator>DIBAS MOHAMMED I</creator><scope>EVB</scope></search><sort><creationdate>20191129</creationdate><title>3-1-1H--4--2- PHARMACEUTICAL COMPOSITIONS COMPRISING 3-1-1H-IMIDAZOL-4-YLETHYL-2-METHYLPHENYLMETHANOL</title><author>DONELLO JOHN E ; GIL DANIEL W ; DIBAS MOHAMMED I</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR20190133071A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; kor</language><creationdate>2019</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DONELLO JOHN E</creatorcontrib><creatorcontrib>GIL DANIEL W</creatorcontrib><creatorcontrib>DIBAS MOHAMMED I</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DONELLO JOHN E</au><au>GIL DANIEL W</au><au>DIBAS MOHAMMED I</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>3-1-1H--4--2- PHARMACEUTICAL COMPOSITIONS COMPRISING 3-1-1H-IMIDAZOL-4-YLETHYL-2-METHYLPHENYLMETHANOL</title><date>2019-11-29</date><risdate>2019</risdate><abstract>본 발명은 [3-(1-(1H-이미다졸-4-일)에틸)-2-메틸페닐] 메탄올 또는 이것의 거울상체, 이것의 호변체, 이들을 함유하는 약제학적 조성물의 치료적 유효량을 투여하는 단계를 포함하는 이러한 치료가 필요한 대상체에서 안압을 강하시키는 방법 및 및 약제로서 이들의 용도에 관한 것이다.
The present invention provides a pharmaceutical composition comprising (S)-(3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl)methanol or a salt thereof for use in a method of treating a condition in a mammal selected from ischemic neuropathy, optic neuropathy, corneal pain, a retinal degenerative condition, skin erythema (redness) and inflammation, rosacea and acne.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; kor |
recordid | cdi_epo_espacenet_KR20190133071A |
source | esp@cenet |
subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | 3-1-1H--4--2- PHARMACEUTICAL COMPOSITIONS COMPRISING 3-1-1H-IMIDAZOL-4-YLETHYL-2-METHYLPHENYLMETHANOL |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T23%3A51%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DONELLO%20JOHN%20E&rft.date=2019-11-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR20190133071A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |